New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SLANG Worldwide Inc.
SLGWF
Shape
US Flag

PNK

Unprofitable

Unprofitable

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Nov 2024

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Nov 2024

0.01USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-16%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

87%

Quote Panel

Shape
Updated October 24, 2024
1W 10.64 % 1M -62.59 % 3M -62.86 % 1Y -85.71 %

Key Metrics

Shape
  • Market Cap

    1.19M


  • Shares Outstanding

    229.18M


  • Share in Float

    213.51M


  • Dividende

    0


  • Earning Date

    26 Nov 2024


  • Price Target

    0.0052


  • Average Volume

    45433


  • Beta

    1.133


  • Range

    0.0041-0.041


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://slangww.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.06x

P/S Ratio

-0.08x

P/B Ratio

-1.5

Debt/Equity

-107.0%

Net Margin

$-0.1

EPS

How SLGWF compares to sector?

P/E Ratio

Relative Strength

Shape

SLGWF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.04
vs -0.12

Q2.22

arrow
arrow

N/A

-0.11
vs -0.05

Q3.22

arrow
arrow

N/A

-0.06
vs -0.09

Q4.22

arrow
arrow

N/A

-0.15
vs -0.38

Q1.23

arrow
arrow

N/A

-0.02
vs -0.04

Q2.23

arrow
arrow

N/A

-0.01
vs -0.11

Q3.23

arrow
arrow

N/A

-0.03
vs -0.06

Q4.23

arrow
arrow

N/A

-0.04
vs -0.15

Q1.24

arrow
arrow

N/A

-0.03
vs -0.02

Q2.24

arrow
arrow

N/A

-0.04
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-16%

8.4M  vs 9.9M

Q2.22

arrow
arrow

-13%

9.9M  vs 11.3M

Q3.22

arrow
arrow

-19%

8.2M  vs 10.1M

Q4.22

arrow
arrow

+82%

11.8M  vs 6.5M

Q1.23

arrow
arrow

+29%

10.8M  vs 8.4M

Q2.23

arrow
arrow

-15%

8.4M  vs 9.9M

Q3.23

arrow
arrow

+11%

9.1M  vs 8.2M

Q4.23

arrow
arrow

-38%

7.3M  vs 11.8M

Q1.24

arrow
arrow

-35%

7M  vs 10.8M

Q2.24

arrow
arrow

-26%

6.3M  vs 8.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-21%

-0.21
vs -0.44

Q4.22

arrow
arrow

-126%

-1.26
vs -0.21

Q1.23

arrow
arrow

-18%

-0.18
vs -1.26

Q2.23

arrow
arrow

-31%

-0.31
vs -0.18

Q3.23

arrow
arrow

-102%

-1.02
vs -0.31

Q4.23

arrow
arrow

+206%

2.06
vs -1.02

Q1.24

arrow
arrow

+60%

0.6
vs 2.06

Q2.24

arrow
arrow

+53%

0.53
vs 0.6

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News